ASRM Responds to Supreme Court Ruling on Mifepristone
For Immediate Release
Washington, DC – “We are thrilled that a unanimous Supreme Court has rejected the ideologically driven lower court decisions on access to mifepristone, reversing an action that has already endangered too many people in need of healthcare. The decision further affirms the robust drug safety program at the United States FDA.
We are pleased that Americans will retain access to this essential medication, and that physicians will be able to provide evidence-based care for their patients. We hope that this marks a turning point in how our nation’s decision-makers evaluate access to reproductive healthcare.”
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
For media inquiries regarding this press release contact:
Sean Tipton
ASRM Chief Advocacy and Policy Officer
E: stipton@asrm.org
Anna Hovey
Advocacy Engagement Specialist
E: ahovey@asrm.org
J. Benjamin Younger Office of Public Affairs
726 7th St. SE
Washington, DC 20003
Tel: (202) 863-2494
Press Releases
Check out these press releases as well
ASRM Launches its Clinical Embryology Learning Laboratory program in Collaboration with SRBT, with the Support of CooperSurgical, Inc.
ASRM launches the Clinical Embryology Learning Laboratory program with SRBT and CooperSurgical, offering advanced training for embryologists. Enrollment opens July 2025.
ASRM Congress & Expo is Underway
The ASRM Congress & Expo is underway in Denver through Wednesday, October 23.
ASRM Releases Congressional Scorecard
Discover ASRM's first Congressional scorecard, detailing positions of the 118th Congress on key reproductive legislation to guide ASRM members in elections.
ASRM Launches National Campaign in Support of Reproductive Rights Ballot Measures
ASRM launches a national campaign supporting reproductive rights ballot measures in 10 states with ads, endorsements, and voter engagement efforts.
The News from ASRM
Latest News
An indispensable news digest for reproductive scientists, clinicians and allied health professionals. The Latest News posts are available to ASRM members in good standing only.
ASRM Press Releases/Bulletins
ASRM Press Releases and Bulletins are published by ASRM's Office of Public Affairs to inform the press and Society members of important recent developments.
Legally Speaking Column
Legally Speaking is a column highlighting recent court decisions affecting the assisted reproductive technologies and the families they create, written by Susan L. Crockin, J.D. and guest authors who offer unique perspectives and expertise on significant legal topics.
Topic Resources
Changes Ahead: Abortion Policy Proposals Affecting Reproductive Medicine
In January 2023, lawmakers reconvened for the first legislative sessions since the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Org. View the Report
States' Abortion Laws Potential Implications for Reproductive Medicine
This report is the second in a series from the ASRM Center for Policy and Leadership (CPL), a non-partisan think tank. View the Report
The Potential Impact of States’ Abortion Trigger Laws on Reproductive Medicine
In thirteen states, so-called “trigger” laws have and are set to take effect which ban or severely restrict abortion care. View the Report
ASRM Advocacy
The U.S. Supreme Court’s opinion in Dobbs v. Jackson Women’s Health Organization overturned the nearly 50-year precedent set by Roe v. Wade. See what ASRM is advocating
